The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials

被引：0
|
作者：
E Segelov
D Chan
J Shapiro
T J Price
C S Karapetis
N C Tebbutt
N Pavlakis
机构：
[1] St Vincent's Clinical School,
[2] University of New South Wales,undefined
[3] Royal North Shore Hospital,undefined
[4] St Leonards,undefined
[5] Monash University and Cabrini Hospital,undefined
[6] The Queen Elizabeth Hospital and University of Adelaide,undefined
[7] Flinders University and Flinders Medical Centre,undefined
[8] Flinders Centre for Innovation in Cancer,undefined
[9] Austin Health,undefined
来源：
British Journal of Cancer | 2014年 / 111卷
关键词：
colorectal; biological; meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1122 / 1131
页数：9
相关论文
共 50 条
  • [1] The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials
    Segelov, E.
    Chan, D.
    Shapiro, J.
    Price, T. J.
    Karapetis, C. S.
    Tebbutt, N. C.
    Pavlakis, N.
    BRITISH JOURNAL OF CANCER, 2014, 111 (06) : 1122 - 1131
  • [2] Capecitabine/oxaliplatin as first-line treatment for metastatic colorectal cancer: a meta-analysis
    Zhao, G.
    Gao, P.
    Yang, K. H.
    Tian, J. H.
    Ma, B.
    COLORECTAL DISEASE, 2010, 12 (07) : 615 - 623
  • [3] Early tumor shrinkage after first-line medical treatment of metastatic colorectal cancer: a meta-analysis
    Colloca, Giuseppe A.
    Venturino, Antonella
    Guarneri, Domenico
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2019, 24 (03) : 231 - 240
  • [4] Early tumor shrinkage after first-line medical treatment of metastatic colorectal cancer: a meta-analysis
    Giuseppe A. Colloca
    Antonella Venturino
    Domenico Guarneri
    International Journal of Clinical Oncology, 2019, 24 : 231 - 240
  • [5] Network Meta-analysis of First-Line Systemic Treatment for Patients With Metastatic Colorectal Cancer
    Xu, Shan
    Sak, Ali
    Erol, Yasin Bahadir
    CANCER CONTROL, 2021, 28
  • [6] Safety of first-line systemic therapy in patients with metastatic colorectal cancer: a network meta-analysis of randomized controlled trials
    Zhan, Yanrong
    Cheng, Xianwen
    Mei, Pingping
    Tan, Shufa
    Feng, Wenzhe
    Jiang, Hua
    BMC CANCER, 2024, 24 (01)
  • [7] Efficacy of bevacizumab in first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysis
    Baraniskin, Alexander
    Buchberger, Barbara
    Pox, Christian
    Graeven, Ulli
    Holch, Julian W.
    Schmiegel, Wolff
    Heinemann, Volker
    EUROPEAN JOURNAL OF CANCER, 2019, 106 : 37 - 44
  • [8] The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta- analysis of randomized trials
    Jang, Hyun Joo
    Kim, Bum Jun
    Kim, Jung Han
    Kim, Hyeong Su
    ONCOTARGET, 2017, 8 (42) : 73009 - 73016
  • [9] The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trials
    Holch, Julian Walter
    Ricard, Ingrid
    Stintzing, Sebastian
    Modest, Dominik Paul
    Heinemann, Volker
    EUROPEAN JOURNAL OF CANCER, 2017, 70 : 87 - 98
  • [10] Role of cetuximab in first-line treatment of metastatic colorectal cancer
    Miguel Jhonatan Sotelo
    Beatriz García-Paredes
    Carlos Aguado
    Javier Sastre
    Eduardo Díaz-Rubio
    World Journal of Gastroenterology, 2014, (15) : 4208 - 4219
12345